simple obesity
Conditions
Interventions
Acupoint embedding group:Acupoint embedding, treatment course: 1 time /2 weeks, 3 times for 1 course of treatment. A total of 8 weeks (the menstrual period of female patients was suspended, and the ti
Nutrition management group:Mainly guided by the academic thought of "harmony to the middle", combined with the differentiation of the patients constitution, the patients life style guidance, diet, exe
Sponsors
Huaibei People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 58 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of simple obesitys; Weight: Broca method: Standard body mass = [(height -100cm*0.9(kg)], with body mass exceeding 20% of standard body mass as the standard for obesity. Among them, 20% to 30% of body weight exceeding standard body weight is mild obesity, 30% to 40% of body weight exceeding standard body weight is moderate obesity, and more than 50% of body weight exceeding standard body weight is severe obesity. Body Mass Index (BMI) Body mass (kg)/height (?), referring to the "Redefinition and Treatment of Obesity in the Asia-Pacific Region" guidance manual published in 2000, 23kg/m2=BMI< 24.9kg/? is overweight, BMI=25.0 kg/m2 is obese. Fat percentage F% : body fat percentage (%)= body fat/body mass *100%. Obesity: female =30%. People who meet 2 or more of the above three items and exclude secondary obesity caused by other reasons (pituitary disease, endocrine disease, etc.) can be diagnosed with simple obesity.(2) Age 18-58 years old, gender is not limited; (3) Voluntarily accept various acupuncture treatment and cooperate with various tests, and can cooperate with the entire treatment process, and all patients sign informed consent for treatment.
Exclusion criteria
Exclusion criteria: (1) Patients with secondary obesity; (2) Patients with diabetes, major organic diseases such as heart, brain, liver and kidney, infectious diseases, blood system diseases, and mental diseases; (3) have received Chinese and western medicine treatment related to this disease within one month; (4) patients with critical illness who are difficult to accurately evaluate the effectiveness and safety of this treatment; (5) For some reason, the treatment is not accepted or completed according to the provisions, and the efficacy cannot be judged or the data is incomplete; (6) Poor compliance, can not adhere to the treatment; (7) Pregnant and lactating women. (8) Patients with MRI contraindications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Head MRI brain function analysis;Intestinal flora analysis;Ghrelin ;Leptin;Glucagon-like peptide-1; | — |
Secondary
| Measure | Time frame |
|---|---|
| Body composition analysis; | — |
Countries
China
Contacts
Public ContactLi Xiaomin
Huaibei People's Hospital
Outcome results
None listed